Homology Medicines, Inc.

( )
FIXX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 8.11%169.500.0%$1483.94m
NVAXNovavax, Inc. 2.25%212.8380.0%$625.43m
SNSSSunesis Pharmaceuticals, Inc. 3.48%8.040.7%$562.03m
AMGNAmgen, Inc. -0.14%258.781.3%$554.57m
ILMNIllumina, Inc. 1.24%403.333.5%$501.88m
REGNRegeneron Pharmaceuticals, Inc. 0.41%506.482.7%$449.94m
GILDGilead Sciences, Inc. 0.62%66.791.0%$433.53m
BNTXBioNTech SE 3.60%161.800.0%$385.45m
VRTXVertex Pharmaceuticals, Inc. -0.18%219.761.9%$373.88m
ALXNAlexion Pharmaceuticals, Inc. 1.14%168.442.0%$372.56m
BIIBBiogen, Inc. -1.23%269.851.7%$244.93m
CRSPCRISPR Therapeutics AG 2.68%124.930.6%$186.56m
NBIXNeurocrine Biosciences, Inc. 0.91%97.034.9%$178.13m
EXASEXACT Sciences Corp. 2.49%128.7518.4%$165.21m
OCGNOcugen, Inc. 17.75%6.500.0%$162.52m

Company Profile

Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the design and development of treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing, and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.